The study found 10-year survival of 73·4% (67·4–78·5) for BRCA1/2 vs 70·1% (67·7–72·3) for non BRCA breast cancer compared to the lower 95% CI of 86.9% in our population. The gene discussed is BRCA1; the disease is breast cancer.